IRIS
DIOTALLEVI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.988
EU - Europa 853
AS - Asia 570
SA - Sud America 155
AF - Africa 75
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.969
SG - Singapore 230
RU - Federazione Russa 178
IT - Italia 170
CN - Cina 160
BR - Brasile 142
SE - Svezia 136
IE - Irlanda 133
HK - Hong Kong 108
DE - Germania 44
CI - Costa d'Avorio 41
GB - Regno Unito 39
FR - Francia 38
UA - Ucraina 34
IN - India 32
MA - Marocco 25
FI - Finlandia 21
NL - Olanda 14
BE - Belgio 10
CA - Canada 10
AT - Austria 9
GR - Grecia 8
IQ - Iraq 8
DK - Danimarca 6
JP - Giappone 6
AU - Australia 5
CZ - Repubblica Ceca 5
ES - Italia 5
BD - Bangladesh 4
CU - Cuba 4
KR - Corea 4
TR - Turchia 4
AR - Argentina 3
MX - Messico 3
VE - Venezuela 3
ZA - Sudafrica 3
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
KE - Kenya 2
NI - Nicaragua 2
PH - Filippine 2
PY - Paraguay 2
AM - Armenia 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.648
Salva come PNG Salva come JPEG
Città #
Chandler 385
Des Moines 248
Ashburn 149
Singapore 142
Dublin 125
Boardman 119
New York 108
Hong Kong 107
Fairfield 88
The Dalles 60
Jacksonville 56
Lawrence 46
Princeton 46
Woodbridge 45
Moscow 42
Abidjan 40
Wilmington 40
Seattle 35
Cambridge 27
San Mateo 27
Houston 26
Los Angeles 23
Centro 21
Guangzhou 20
Pune 20
London 19
Ann Arbor 18
Turin 18
Ancona 17
San Diego 17
Washington 16
Beijing 15
Munich 15
Dallas 13
Helsinki 11
Redmond 11
Brussels 10
Boydton 9
Shanghai 9
São Paulo 9
Turku 8
Rio de Janeiro 7
Rome 7
Toronto 7
Wuhan 7
Cagliari 6
Norwalk 6
Santa Clara 6
Nuremberg 5
Boston 4
Brooklyn 4
Civitanova Marche 4
Havana 4
Najaf 4
Naples 4
Olomouc 4
Polverigi 4
San Vito Chietino 4
Tokyo 4
Vienna 4
Clifton 3
Cuiabá 3
Falerone 3
Frankfurt am Main 3
Gatchina 3
Hounslow 3
Johannesburg 3
Kingston 3
Nanjing 3
Porto Alegre 3
San Francisco 3
Shenzhen 3
Sydney 3
Wuxi 3
Allerød Municipality 2
Ascoli Piceno 2
Atlanta 2
Banhā 2
Basra 2
Belo Horizonte 2
Brasília 2
Cascina 2
Castelfidardo 2
Catania 2
Cernusco sul Naviglio 2
Chicago 2
Curitiba 2
Delhi 2
Florence 2
Ginosa 2
Guarulhos 2
Guwahati 2
Hangzhou 2
Heze 2
Itajaí 2
Itaquaquecetuba 2
Jiaxing 2
Kensington 2
Kilburn 2
Ludhiana 2
Totale 2.449
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate 91
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 91
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 90
miRNome analysis in psoriatic patients treated with anti IL- 23: a cohort study 88
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 84
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 83
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 82
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 81
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 81
Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital 79
Reticulated acanthoma with sebaceous differentiation 76
Granuloma faciale successfully treated with ingenol mebutate 75
Safety update of etanercept treatment for moderate to severe plaque psoriasis 74
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 74
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 73
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 73
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 72
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 72
The efficacy of in vivo administration of Apremilast on mesenchymal stem cells derived from psoriatic patients 69
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 68
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 68
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 67
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 67
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 67
Topical application of fumaric acid esters improves appearance of nail psoriasis 67
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 66
Novel Therapeutic Approaches and Targets for Treatment of Psoriasis 66
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 66
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 65
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 65
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 63
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 59
Acral Leukoderma: Is It Always Vitiligo? 58
Asymptomatic pigmentation of the skin in a child: babywipes, once again 57
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 57
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 55
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 55
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 54
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 53
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 52
Saliva and Oral Diseases 51
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 51
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 50
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 48
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 48
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 46
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 45
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 44
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 44
InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study 41
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 41
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 39
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 39
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 38
Trichorhinophalangeal syndrome: a case report and brief literature review. 37
Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review 31
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 30
miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review 29
Biological treatments for pediatric psoriasis: state of the art and future perspectives 28
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 28
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 27
Role of daptomycin in cutaneous wound healing: a narrative review 25
The pharmacological treatment and management of hyperhidrosis 24
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study 22
Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: A multicentre study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 22
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness 20
Mesenchymal Stem Cells and Psoriasis: Systematic Review 20
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 17
Totale 3.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 0 0 0 0 0 0 18
2020/2021287 14 21 24 17 22 2 9 19 29 27 73 30
2021/2022368 10 41 3 2 42 21 3 28 28 7 98 85
2022/20231.090 81 112 67 104 61 335 1 51 191 2 56 29
2023/2024650 88 11 59 59 81 179 13 55 4 24 23 54
2024/20251.295 152 119 35 42 83 51 128 63 252 89 163 118
Totale 3.788